Wendy S. Johnson - 08 Jul 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role
Chief Development Officer
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Issuer symbol
OKUR
Transactions as of
08 Jul 2021
Net transactions value
+$220,120
Form type
4
Filing time
09 Jul 2021, 18:52:11 UTC
Previous filing
21 Jun 2021
Next filing
15 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Options Exercise $220,120 +111,736 $1.97 111,736 08 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPHM Stock option (right to buy) Options Exercise $0 -111,736 -100% $0.000000* 0 08 Jul 2021 Common Stock 111,736 $1.97 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.